{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:10:42Z","timestamp":1790172642770,"version":"4.1.0"},"reference-count":70,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2019,4,3]]},"DOI":"10.1080\/14737175.2019.1593142","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T10:13:43Z","timestamp":1553249623000},"page":"301-310","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":26,"title":["Stiripentol for the treatment of seizures associated with Dravet syndrome"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9096-1694","authenticated-orcid":false,"given":"Catherine","family":"Chiron","sequence":"first","affiliation":[{"name":"Inserm NeuroDiderot, InDev, Paris, France"},{"name":"Neurospin, CEA, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,4,2]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2006.10.001"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1586\/ern.09.136"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03008.x"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2012.04.009"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-012-0004-3"},{"issue":"11","key":"CIT0006","first-page":"CD010483","volume":"19","author":"Brigo F","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2016.1145657"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2016.1161026"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-017-0432-1"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-1807"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-52891-9.00065-8"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1998.tb01413.x"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-693X(02)00090-8"},{"key":"CIT0014","doi-asserted-by":"crossref","unstructured":"de Lange IM, Gunning B, Sonsma ACM, et al. Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes. Epilepsia. 2018;59(6):1154-1165.","DOI":"10.1111\/epi.14191"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03007.x"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-018-0511-y"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00497.x"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2008.06.004"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12401"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2012.11.002"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2012.03497.x"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3410"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa1299"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.23688"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13802"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03157-3"},{"issue":"8","key":"CIT0027","first-page":"S155","volume":"43","author":"Guerrini R","year":"2002","journal-title":"Epilepsia"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31825dc4a6"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2014.03.009"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0592-7"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14536"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(97)90044-8"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.007237"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2014.02.008"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb02048.x"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-014-0223-5"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2016.12.014"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000367"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-964867"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2016.05.012"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.3109\/03602532.2013.849268"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005254"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.5414\/CP203276"},{"key":"CIT0044","volume-title":"Fenfluramine (fintepla\u00ae) reduces convulsive seizure frequency in Dravet syndrome patients receiving an antiepileptic drug treatment regimen containing stiripentol: a Phase 3, randomized, placebo-controlled clinical trial","author":"Nabbout R","year":"2018"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01423.x"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02179.x"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2015.03.012"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12303"},{"key":"CIT0049","first-page":"883073818811538","volume":"26","author":"Pembegul Y\u0131ld\u0131z E","year":"2018","journal-title":"J Child Neurol"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.13704"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12532"},{"key":"CIT0052","unstructured":"Diacomit: EPAR - product information 2013. [cited 2019 Mar 22]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_Product_Information\/human\/000664\/WC500036518.pdf"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02466.x"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr129"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12611"},{"key":"CIT0056","unstructured":"Biocodex. BC.627 - DIAVEY - DIACOMIT Post-Marketing Survey (Stiripentol). Post-authorization safety study, final study report. 14 December 2012."},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611618"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2014.03.014"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.12709"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2014.10.014"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2014.04.003"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003716"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03107.x"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2014.12.028"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12403"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12888"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2016.10.014"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13407"},{"key":"CIT0069","volume-title":"ZX008 (fenfluramine HCI oral solution) in Dravet syndrome: results of a Phase 3, randomized, double-blind, placebo-controlled trial","author":"Lagae L","year":"2017"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2018.1552937"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2019.1593142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T19:32:35Z","timestamp":1598643155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737175.2019.1593142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,3]]}},"alternative-id":["10.1080\/14737175.2019.1593142"],"URL":"https:\/\/doi.org\/10.1080\/14737175.2019.1593142","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-01-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}